0
     

Report Added
Report already added
Global Antibody Market Research Report 2022(Status and Outlook)

Global Antibody Market Research Report 2022(Status and Outlook)

Report Overview

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 5%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, IgG is the largest segment, with a share about 8%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
The Global Antibody Market Size was estimated at USD 8643.8 million in 2021 and is projected to reach USD 12451.83 million by 2028, exhibiting a CAGR of 5.35% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antibody Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antibody market in any manner.
Global Antibody Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company
•Roche
•Johnson and Johnson
•Merck
•Novartis
•AbbVie
•Amgen
•Pfizer
•Bayer
•Lilly
•Bristol-Myers Squibb
•GlaxoSmithKline
•Biogen
•AstraZeneca
•Sanofi
•Alexion Pharmaceuticals
•Seattle Genetics

Market Segmentation (by Type)
•IgM
•IgG
•IgA
•Other

Market Segmentation (by Application)
•Therapeutic
•Research
•Diagnostic

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Antibody Market
• Overview of the regional outlook of the Antibody Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antibody Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


TABLE OF CONTENTS

1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antibody
1.2 Key Market Segments
1.2.1 Antibody Segment by Type
1.2.2 Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antibody Market Overview
2.1 Global Market Overview
2.1.1 Global Antibody Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Antibody Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antibody Market Competitive Landscape
3.1 Global Antibody Sales by Manufacturers (2017-2022)
3.2 Global Antibody Revenue Market Share by Manufacturers (2017-2022)
3.3 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antibody Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Antibody Sales Sites, Area Served, Product Type
3.6 Antibody Market Competitive Situation and Trends
3.6.1 Antibody Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antibody Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antibody Industry Chain Analysis
4.1 Antibody Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antibody Market

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antibody Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antibody Sales Market Share by Type (2017-2022)
6.3 Global Antibody Market Size Market Share by Type (2017-2022)
6.4 Global Antibody Price by Type (2017-2022)
7 Antibody Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antibody Market Sales by Application (2017-2022)
7.3 Global Antibody Market Size (M USD) by Application (2017-2022)
7.4 Global Antibody Sales Growth Rate by Application (2017-2022)
8 Antibody Market Segmentation by Region
8.1 Global Antibody Sales by Region
8.1.1 Global Antibody Sales by Region
8.1.2 Global Antibody Sales Market Share by Region
8.2 North America
8.2.1 North America Antibody Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antibody Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antibody Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antibody Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antibody Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Roche
9.1.1 Roche Antibody Basic Information
9.1.2 Roche Antibody Product Overview
9.1.3 Roche Antibody Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Antibody SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Johnson and Johnson
9.2.1 Johnson and Johnson Antibody Basic Information
9.2.2 Johnson and Johnson Antibody Product Overview
9.2.3 Johnson and Johnson Antibody Product Market Performance
9.2.4 Johnson and Johnson Business Overview
9.2.5 Johnson and Johnson Antibody SWOT Analysis
9.2.6 Johnson and Johnson Recent Developments
9.3 Merck
9.3.1 Merck Antibody Basic Information
9.3.2 Merck Antibody Product Overview
9.3.3 Merck Antibody Product Market Performance
9.3.4 Merck Business Overview
9.3.5 Merck Antibody SWOT Analysis
9.3.6 Merck Recent Developments
9.4 Novartis
9.4.1 Novartis Antibody Basic Information
9.4.2 Novartis Antibody Product Overview
9.4.3 Novartis Antibody Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Antibody SWOT Analysis
9.4.6 Novartis Recent Developments
9.5 AbbVie
9.5.1 AbbVie Antibody Basic Information
9.5.2 AbbVie Antibody Product Overview
9.5.3 AbbVie Antibody Product Market Performance
9.5.4 AbbVie Business Overview
9.5.5 AbbVie Antibody SWOT Analysis
9.5.6 AbbVie Recent Developments
9.6 Amgen
9.6.1 Amgen Antibody Basic Information
9.6.2 Amgen Antibody Product Overview
9.6.3 Amgen Antibody Product Market Performance
9.6.4 Amgen Business Overview
9.6.5 Amgen Recent Developments
9.7 Pfizer
9.7.1 Pfizer Antibody Basic Information
9.7.2 Pfizer Antibody Product Overview
9.7.3 Pfizer Antibody Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Bayer
9.8.1 Bayer Antibody Basic Information
9.8.2 Bayer Antibody Product Overview
9.8.3 Bayer Antibody Product Market Performance
9.8.4 Bayer Business Overview
9.8.5 Bayer Recent Developments
9.9 Lilly
9.9.1 Lilly Antibody Basic Information
9.9.2 Lilly Antibody Product Overview
9.9.3 Lilly Antibody Product Market Performance
9.9.4 Lilly Business Overview
9.9.5 Lilly Recent Developments
9.10 Bristol-Myers Squibb
9.10.1 Bristol-Myers Squibb Antibody Basic Information
9.10.2 Bristol-Myers Squibb Antibody Product Overview
9.10.3 Bristol-Myers Squibb Antibody Product Market Performance
9.10.4 Bristol-Myers Squibb Business Overview
9.10.5 Bristol-Myers Squibb Recent Developments
9.11 GlaxoSmithKline
9.11.1 GlaxoSmithKline Antibody Basic Information
9.11.2 GlaxoSmithKline Antibody Product Overview
9.11.3 GlaxoSmithKline Antibody Product Market Performance
9.11.4 GlaxoSmithKline Business Overview
9.11.5 GlaxoSmithKline Recent Developments
9.12 Biogen
9.12.1 Biogen Antibody Basic Information
9.12.2 Biogen Antibody Product Overview
9.12.3 Biogen Antibody Product Market Performance
9.12.4 Biogen Business Overview
9.12.5 Biogen Recent Developments
9.13 AstraZeneca
9.13.1 AstraZeneca Antibody Basic Information
9.13.2 AstraZeneca Antibody Product Overview
9.13.3 AstraZeneca Antibody Product Market Performance
9.13.4 AstraZeneca Business Overview
9.13.5 AstraZeneca Recent Developments
9.14 Sanofi
9.14.1 Sanofi Antibody Basic Information
9.14.2 Sanofi Antibody Product Overview
9.14.3 Sanofi Antibody Product Market Performance
9.14.4 Sanofi Business Overview
9.14.5 Sanofi Recent Developments
9.15 Alexion Pharmaceuticals
9.15.1 Alexion Pharmaceuticals Antibody Basic Information
9.15.2 Alexion Pharmaceuticals Antibody Product Overview
9.15.3 Alexion Pharmaceuticals Antibody Product Market Performance
9.15.4 Alexion Pharmaceuticals Business Overview
9.15.5 Alexion Pharmaceuticals Recent Developments
9.16 Seattle Genetics
9.16.1 Seattle Genetics Antibody Basic Information
9.16.2 Seattle Genetics Antibody Product Overview
9.16.3 Seattle Genetics Antibody Product Market Performance
9.16.4 Seattle Genetics Business Overview
9.16.5 Seattle Genetics Recent Developments
10 Antibody Market Forecast by Region
10.1 Global Antibody Market Size Forecast
10.2 Global Antibody Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antibody Market Size Forecast by Country
10.2.3 Asia Pacific Antibody Market Size Forecast by Region
10.2.4 South America Antibody Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antibody by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Antibody Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Antibody by Type (2022-2028)
11.1.2 Global Antibody Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Antibody by Type (2022-2028)
11.2 Global Antibody Market Forecast by Application (2022-2028)
11.2.1 Global Antibody Sales (K Units) Forecast by Application
11.2.2 Global Antibody Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings

Report Title: Global Antibody Market Research Report 2022(Status and Outlook)


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline